Wikisage, the free encyclopedia of the second generation, is digital heritage

Difference between revisions of "BIA 10-2474"

From Wikisage
Jump to navigation Jump to search
m
 
Line 2: Line 2:
  
 
The molecule from Bial pharmaceutical company (Portela ca, Portugal) intended for enhancement of anandamide levels, its has a licking score (a formalin paw test) comparable to reference molecule [[gabapentine]] 300mg and 10 mg /Kg has a tail flick test maximum at 8 hour
 
The molecule from Bial pharmaceutical company (Portela ca, Portugal) intended for enhancement of anandamide levels, its has a licking score (a formalin paw test) comparable to reference molecule [[gabapentine]] 300mg and 10 mg /Kg has a tail flick test maximum at 8 hour
 
+
[[File:Bia102474 corrected.svg.png|miniature]]
 
[http://worldpediaen.wikia.com/wiki/BIA_10-2474?oldid=5467 Worldpedia BIA 10 2474]
 
[http://worldpediaen.wikia.com/wiki/BIA_10-2474?oldid=5467 Worldpedia BIA 10 2474]
 
  
 
{{Wikidata|Q22082929}}
 
{{Wikidata|Q22082929}}
 
  
 
[[Category:Clinical trial disasters]]
 
[[Category:Clinical trial disasters]]

Latest revision as of 14:26, 24 July 2019

In January 2016 an experimental study on a fatty acid amide hydrolase inhibitor of the type FIH, led to death of a healthy volunteer. A case of cummulative toxicity.

The molecule from Bial pharmaceutical company (Portela ca, Portugal) intended for enhancement of anandamide levels, its has a licking score (a formalin paw test) comparable to reference molecule gabapentine 300mg and 10 mg /Kg has a tail flick test maximum at 8 hour miniature Worldpedia BIA 10 2474

Q22082929 op Wikidata  Interwiki via Wikidata